GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines

Provided By Globe Newswire

Last update: Jan 9, 2023

BOSTON and PROVIDENCE, R.I., Jan. 09, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (Nasdaq:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.